Cornerstone Advisors Asset Management’s AbbVie ABBV Stock Holding History

Cornerstone Advisors Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$750K	Sell	2,979 -372	-11%	-$80K	0.1%	84
2026 Q1	$729K	Buy	3,351 +95	+3%	+$21.1K	0.11%	83
2025 Q4	$744K	Buy	3,256 +480	+17%	+$109K	0.12%	75
2025 Q3	$643K	Buy	2,776 +147	+6%	+$29.9K	0.11%	81
2025 Q2	$488K	Hold	2,629	–	–	0.09%	84
2025 Q1	$551K	Hold	2,629	–	–	0.11%	87
2024 Q4	$467K	Buy	2,629 +129	+5%	+$23.7K	0.1%	84
2024 Q3	$494K	Hold	2,500	–	–	0.11%	81
2024 Q2	$429K	Hold	2,500	–	–	0.12%	79
2024 Q1	$455K	Hold	2,500	–	–	0.16%	75
2023 Q4	$387K	Hold	2,500	–	–	0.15%	79
2023 Q3	$373K	Sell	2,500 -25	-1%	-$3.67K	0.15%	75
2023 Q2	$340K	Buy	2,525 +7	+0.3%	+$1.03K	0.15%	74
2023 Q1	$401K	Hold	2,518	–	–	0.2%	64
2022 Q4	$407K	Hold	2,518	–	–	0.22%	67
2022 Q3	$338K	Buy	2,518 +18	+0.7%	+$2.58K	0.26%	48
2022 Q2	$383K	Hold	2,500	–	–	0.27%	52
2022 Q1	$405K	Buy	+2,500	New	+$363K	0.28%	51

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cornerstone Advisors Asset Management's ABBV Position: Q2 2026 in Review

Cornerstone Advisors Asset Management reduced its AbbVie (ABBV) stake by 11% in Q2 2026, selling an estimated $80K and leaving 2,979 shares worth $750K. The position accounts for 0.1% of the portfolio, ranked #84.

Cornerstone Advisors Asset Management first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Cornerstone Advisors Asset Management held 2,979 shares of AbbVie worth $750K as of Q2 2026.
Cornerstone Advisors Asset Management sold 372 AbbVie shares in Q2 2026, an estimated $80K.
AbbVie made up 0.1% of Cornerstone Advisors Asset Management's portfolio in Q2 2026, its #84 holding.
Cornerstone Advisors Asset Management first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cornerstone Advisors Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.